var data={"title":"Toxic shock syndrome due to Clostridium sordellii","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Toxic shock syndrome due to Clostridium sordellii</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/contributors\" class=\"contributor contributor_credentials\">Denis Spelman, MBBS, FRACP, FRCPA, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/contributors\" class=\"contributor contributor_credentials\">John G Bartlett, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Oct 10, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Clostridium sordellii</em> is part of the normal flora of the vagina and may gain entry to the uterus via the cervix during spontaneous or induced abortion, childbirth, or menstruation. <em>C. sordellii</em> is a cause of toxic shock syndrome associated with gynecologic procedures, childbirth, and abortion (including spontaneous, surgical, and medical abortion) [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/1-6\" class=\"abstract_t\">1-6</a>]. <em>C. sordellii</em> toxic shock (CSTS) is an uncommonly reported condition with a limited number of case reports and small case series.</p><p>The epidemiology, microbiology, pathogenesis, clinical manifestations, diagnosis, and management of CSTS syndrome will be reviewed here. Other issues related to clostridial myonecrosis are discussed separately. (See <a href=\"topic.htm?path=clostridial-myonecrosis\" class=\"medical medical_review\">&quot;Clostridial myonecrosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>C. sordellii</em> can be found in soil, sewage, and the gastrointestinal tracts of humans and animals [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/7\" class=\"abstract_t\">7</a>]. <em>C. sordellii</em> has been identified in the gastrointestinal tracts of 0.5 percent of humans [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>].</p><p>Healthy women can harbor clostridial species in the vagina. <em>Clostridium perfringens</em> is the most common clostridial species (4 to 18 percent of healthy women); <em>C. sordellii</em> is less common (0.5 to 10 percent of healthy women) [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8-11\" class=\"abstract_t\">8-11</a>]. Clostridial vaginal colonization following abortion has been observed in up to 29 percent of women [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/10\" class=\"abstract_t\">10</a>]. Similarly, fecal vaginal contamination during or after childbirth could be the source of <em>C. sordelli</em> infection [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>].</p><p>The incidence of <em>C. sordellii</em> toxic shock (CSTS) is unknown; one review of death certificates suggested that CSTS was the cause of 1 in 200 deaths among young women of childbearing age [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Risk factors for CSTS include abortion, childbirth, intravenous drug use, and other gynecologic procedures.</p><p class=\"headingAnchor\" id=\"H185458999\"><span class=\"h3\">Abortion</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Medically induced and spontaneous abortions are risk factors for CSTS [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. The sentinel description of abortion and CSTS included four deaths within one week of medically induced abortions using intravaginal <a href=\"topic.htm?path=misoprostol-drug-information\" class=\"drug drug_general\">misoprostol</a> and oral <a href=\"topic.htm?path=mifepristone-drug-information\" class=\"drug drug_general\">mifepristone</a> [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/3,4,12,13\" class=\"abstract_t\">3,4,12,13</a>]. Additional cases have been subsequently reported [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8,14,15\" class=\"abstract_t\">8,14,15</a>]. (See <a href=\"topic.htm?path=first-trimester-medication-abortion-termination-of-pregnancy\" class=\"medical medical_review\">&quot;First-trimester medication abortion (termination of pregnancy)&quot;</a>.)</p><p><a href=\"topic.htm?path=misoprostol-drug-information\" class=\"drug drug_general\">Misoprostol</a> is a synthetic prostaglandin that stimulates heavy vaginal secretions when administered by the intravaginal route and can impair innate immune responses of the female reproductive tract. It has also been postulated that the intravaginal insertion of misoprostol may lead to ascending infection. (See <a href=\"topic.htm?path=misoprostol-as-a-single-agent-for-medical-termination-of-pregnancy\" class=\"medical medical_review\">&quot;Misoprostol as a single agent for medical termination of pregnancy&quot;</a>.)</p><p><a href=\"topic.htm?path=mifepristone-drug-information\" class=\"drug drug_general\">Mifepristone</a> inhibits the action of progesterone and can block glucocorticoid receptors, which may favor growth of <em>C. sordellii</em> [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/14,16\" class=\"abstract_t\">14,16</a>].</p><p class=\"headingAnchor\" id=\"H185460572\"><span class=\"h3\">Childbirth</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>One review described eight fatal cases of CSTS within one week of childbirth in previously healthy women following normal childbirth [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. The source of <em>C. sordellii</em> is likely the vagina, where this organism may be a part of the normal flora and may gain entry to the uterus through the cervix during childbirth.</p><p class=\"headingAnchor\" id=\"H185460601\"><span class=\"h3\">Intravenous drug use</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There have been outbreaks of necrotizing soft tissue infections associated with subcutaneous or intramuscular infection of black-tar heroin (&quot;skin or muscle popping&quot;) [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/17-19\" class=\"abstract_t\">17-19</a>]. In one review including 10 cases of <em>C. sordellii</em> infection occurring in intravenous drug users, 50 percent were fatal [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. Possible sources of <em>C. sordellii</em> include soil contamination of the drug or paraphernalia; the organism can multiply in the setting of local ischemia with resultant anaerobic conditions.</p><p>Necrotizing infections are discussed separately. (See <a href=\"topic.htm?path=necrotizing-soft-tissue-infections\" class=\"medical medical_review\">&quot;Necrotizing soft tissue infections&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H185460668\"><span class=\"h3\">Other gynecologic cases</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>CSTS has been reported following procedures on the cervix including laser therapy and conization [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/6\" class=\"abstract_t\">6</a>]. A fatal case of spontaneous <em>C. sordellii</em> endometritis has been reported, as has a fatal case following episiotomy infection [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/20-23\" class=\"abstract_t\">20-23</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The genus <em>Clostridium</em> consists of anaerobic gram-positive, spore-forming bacilli most commonly found in soil and in the gastrointestinal tracts of animals and humans. Well-known species include <em>C. perfringens</em>, <em>C. septicum</em>, and <em>C. tetani</em>.</p><p><em>C. sordelli</em> is an anaerobic gram-positive rod with subterminal spores and peritrichous flagella [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/24\" class=\"abstract_t\">24</a>]. The organism grows on blood agar with a small zone of beta-hemolysis [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. It was initially named <em>Bacillus oedematis sporogenes</em>, reflecting the marked edema observed in clinical presentation [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. It has similarities with <em>C. bifermentans</em>, but urease production differentiates these species. Many strains of <em>C. sordellii</em> appear nonpathogenic, but virulent toxin-producing strains cause fatal infections. <em>C. sordelli</em> has been identified from clinical specimens by culture, by matrix-assisted laser <span class=\"nowrap\">desorption/ionization</span> time of flight (MALDI-TOF) [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/25\" class=\"abstract_t\">25</a>], and by molecular methods (including polymerase chain reaction), especially from autopsy tissue [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/26\" class=\"abstract_t\">26</a>].</p><p>Antibiotic susceptibility studies indicate that <em>C. sordelli</em> is susceptible to <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a>, beta-lactams, <a href=\"topic.htm?path=tetracycline-drug-information\" class=\"drug drug_general\">tetracycline</a>, and <a href=\"topic.htm?path=chloramphenicol-drug-information\" class=\"drug drug_general\">chloramphenicol</a> [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/27\" class=\"abstract_t\">27</a>]. The antitoxin properties of clindamycin may be of benefit in addition to its antibiotic effect.</p><p><em>C. sordellii</em> antitoxin is used for identification of <em>Clostridium difficile</em>: the <em>C. sordellii</em> antitoxin neutralizes the cytopathic effect and all pathologic effects caused by <em>C. difficile</em> toxins A and B. (See <a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Clostridium difficile infection in adults: Clinical manifestations and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2537890\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The virulence of <em>C. sordellii</em> is related to production of exotoxins, which may lead to <em>C. sordellii</em> toxic shock even with minimal signs of local infection [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2\" class=\"abstract_t\">2</a>]. Diffuse capillary leak, massive edema, and hemoconcentration probably occur due to one or more exotoxins.</p><p>The most studied toxins are large molecular weight cytotoxins designated lethal toxin (LT) and hemorrhagic toxin (HT). Administration of these toxins to animals results in rapidly spreading edema, necrosis, and shock [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/5\" class=\"abstract_t\">5</a>]. Both have some antigenic and pathophysiological similarities with <em>C. difficile</em> toxins A and B [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/28\" class=\"abstract_t\">28</a>]. The LT inhibits glucocorticoid receptor function and can act to prevent glucocorticoid suppression of tumor necrosis factor-alpha [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/29\" class=\"abstract_t\">29</a>].</p><p>Another toxin, <em>C. sordellii</em> neuraminidase (NanS), modifies vascular cell adhesion molecules and stimulates promyelocytic proliferation [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/30\" class=\"abstract_t\">30</a>]. NanS appears to modulate the leukemoid reaction by preventing margination and movement of leukocytes through the vascular endothelium, such that these cells remain in the circulation, causing profound leukocytosis [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/30\" class=\"abstract_t\">30</a>].</p><p>Sordellilysin is a cholesterol-dependent cytolysin that serves as a cytotoxin in strains without LT [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/31\" class=\"abstract_t\">31</a>]. Non-toxigenic <em>C. sordelli</em> have also been reported [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/32,33\" class=\"abstract_t\">32,33</a>].</p><p class=\"headingAnchor\" id=\"H14704540\"><span class=\"h1\">PATHOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Histological examination of surgical or autopsy tissue may demonstrate acute inflammatory changes, localized thrombosis of blood vessels, and massive coagulation necrosis of the uterine wall [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/16\" class=\"abstract_t\">16</a>]. Autopsy findings include massive pleural effusions and ascites [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2,5,21\" class=\"abstract_t\">2,5,21</a>]. Necrotizing endomyometritis may be found in fatal cases following medical and spontaneous abortions [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/16\" class=\"abstract_t\">16</a>].</p><p>Immunohistochemical and molecular studies have been performed on hysterectomy and other postmortem tissues. Polymerase chain reaction assays on extracted DNA, 16sRNA methodology, and sequencing of amplified products can be used to confirm the presence of clostridial species, <em>C. sordellii</em>, and specific toxin [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/16,26\" class=\"abstract_t\">16,26</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>C. sordellii</em> causes a spectrum of clinical disease, including localized skin infection, bacteremia, and infection localized to a single organ system such as pneumonia, empyema, endocarditis, septic arthritis, omphalitis, and surgical site infection [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/7,24,34-40\" class=\"abstract_t\">7,24,34-40</a>].</p><p><em>C. sordellii</em> toxic shock is characterized by rapid onset of severe illness with shock; the illness frequently occurs in previously healthy individuals [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2\" class=\"abstract_t\">2</a>]. The clinical presentation generally consists of systemic manifestations including edema, effusions, profound leukocytosis, and hemoconcentration, followed by shock and multiorgan failure [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/41\" class=\"abstract_t\">41</a>].</p><p>Early symptoms are often nonspecific and may include nausea, vomiting, lethargy, influenza-like symptoms, and abdominal tenderness [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/21,42\" class=\"abstract_t\">21,42</a>]. Progression from early symptoms to severe disease occurs within hours, and mortality is high [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. The systemic nature of the presentation with the paucity of localizing symptoms may make early diagnosis difficult [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/41\" class=\"abstract_t\">41</a>]. Distinctive clinical features include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rapid development of generalized and massive tissue edema [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8,20\" class=\"abstract_t\">8,20</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural, pericardial, and peritoneal effusions are common [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2,8\" class=\"abstract_t\">2,8</a>]. These develop due to capillary leak from toxin-mediated changes in the vascular endothelium, together with hypoalbuminemia [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2\" class=\"abstract_t\">2</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Profound leukocytosis (leukemoid reaction) consisting of white blood cell (WBC) count &gt;50,000 <span class=\"nowrap\">cells/microL,</span> which can increase to 200,000 <span class=\"nowrap\">cells/microL</span> within 48 hours [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2-4,8,43\" class=\"abstract_t\">2-4,8,43</a>]. In general, an increased percentage of mature and immature neutrophils and increased absolute numbers of lymphocytes and monocytes are observed. The presence of leukemoid reaction is highly predictive of mortality [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. In one study, patients who died had average WBC count of &gt;75,000 <span class=\"nowrap\">cells/mm<sup>3</sup>;</span> survivors had average WBC count of 18,000 <span class=\"nowrap\">cells/mm<sup>3</sup></span> [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemoconcentration is common; hematocrit levels up to 80 percent have been reported [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2,4,5,16,42,43\" class=\"abstract_t\">2,4,5,16,42,43</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Absence of fever [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2,4,8\" class=\"abstract_t\">2,4,8</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Refractory hypotension and tachycardia [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2,8\" class=\"abstract_t\">2,8</a>].</p><p/><p>In postpartum women, the uterus can be large, but usually there is no evidence of retained fetal or placental tissue. Gas in tissues suggests the presence of other organisms such as <em>C. perfringens</em> or <em>Bacteroides </em>species.</p><p><em>C. sordelli</em> is rarely reported in children. However, there is a case report of <em>C. sordelli</em> infection with toxic shock syndrome in a two-year-old boy in the setting of the hemolytic uremic syndrome, in which the organism was isolated from blood cultures [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/44\" class=\"abstract_t\">44</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>C. sordellii</em> infection should be suspected in young women with rapid clinical deterioration in the postpartum period or in the setting of recent abortion or other gynecological procedure [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/20\" class=\"abstract_t\">20</a>]. <em>C. sordellii</em> sepsis should also be suspected in patients who took <a href=\"topic.htm?path=mifepristone-drug-information\" class=\"drug drug_general\">mifepristone</a> within 24 hours of presenting with nausea, vomiting, or diarrhea without fever [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/12\" class=\"abstract_t\">12</a>]. The diagnosis should also be considered in the setting of intravenous drug use, especially with the use of black-tar heroin.</p><p>Empiric antibiotic therapy should be instituted promptly while diagnostic studies are pending. (See <a href=\"#H9\" class=\"local\">'Treatment'</a> below.)</p><p>Blood cultures (both aerobic and anaerobic bottles) should be obtained; in one series, blood cultures were positive in 20 percent of cases [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. Gram stain and cultures of specimens from suspected sites of infection (including vaginal specimens <span class=\"nowrap\">and/or</span> wound aspirates) should be performed. Gram staining may demonstrate mixed gram-negative and gram-positive bacilli; <em>C. sordellii</em> is frequently identified together with other pathogens, such as <em>Peptostreptococcus</em>, <em>Streptococcus milleri</em>, <em>C. perfringens</em>, <em>Escherichia coli</em>, and a variety of other coliforms and anaerobes [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2,5,8,21,45\" class=\"abstract_t\">2,5,8,21,45</a>].</p><p>A complete blood count should be obtained to evaluate for presence of hemoconcentration, leukocytosis, or a leukemoid reaction [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/12\" class=\"abstract_t\">12</a>].</p><p>Computed tomography and ultrasound examinations, in cases related to abortion or childbirth, have demonstrated ascites [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/4,8\" class=\"abstract_t\">4,8</a>], pleural effusions [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/5\" class=\"abstract_t\">5</a>], and a thickened or enlarged uterus [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/5,8\" class=\"abstract_t\">5,8</a>].</p><p>Surgical intervention may be necessary to obtain optimal specimens. In one report, endometrial biopsy was the diagnostic procedure [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/5\" class=\"abstract_t\">5</a>]. Histopathology of resected necrotic tissue <span class=\"nowrap\">and/or</span> intraoperative frozen section biopsies may confirm the presence of necrotizing subcutaneous infection; Gram stain and culture should also be performed [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/20\" class=\"abstract_t\">20</a>].</p><p class=\"headingAnchor\" id=\"H2537646\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of toxic shock due to <em>C. sordellii</em> includes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Retained products of conception &ndash; Both retained products and <em>C. sordellii</em> infection may be associated with pelvic pain <span class=\"nowrap\">and/or</span> uterine tenderness. Fever may be observed in the setting of retained products but is not typically seen in the setting of <em>C. sordellii</em> infection. The diagnosis of retained products of conception is established by ultrasonography. (See <a href=\"topic.htm?path=retained-products-of-conception\" class=\"medical medical_review\">&quot;Retained products of conception&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Postpartum hemorrhage &ndash; Postpartum hemorrhage refers to excessive bleeding following delivery, which can lead to hypotension and tachycardia. <em>C. sordellii</em> infection is also associated with these findings but differs in that hemoconcentration is common. (See <a href=\"topic.htm?path=overview-of-postpartum-hemorrhage\" class=\"medical medical_review\">&quot;Overview of postpartum hemorrhage&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Uterine perforation &ndash; Uterine perforation is associated with abdominal pain, abdominal distension, and hypotension, which can also occur in the setting of <em>C. sordellii</em> infection. The diagnosis is established by direct visualization via hysteroscopy or laparoscopy. (See <a href=\"topic.htm?path=uterine-perforation-during-gynecologic-procedures\" class=\"medical medical_review\">&quot;Uterine perforation during gynecologic procedures&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other causes of toxic shock &ndash; Other causes of toxic shock include <em>Streptococcus pyogenes, Staphylococcus aureus,</em> and <em>C. perfringens</em>. <em>C. sordellii</em> toxic shock may be distinguished from these other causes by clinical history, absence of rash and fever, and profound leukocytosis [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-streptococcal-toxic-shock-syndrome\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome&quot;</a> and <a href=\"topic.htm?path=staphylococcal-toxic-shock-syndrome\" class=\"medical medical_review\">&quot;Staphylococcal toxic shock syndrome&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Treatment of <em>C. sordellii</em> toxic shock (CSTS) syndrome consists of antibiotic therapy, surgical debridement, and aggressive resuscitation [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/20\" class=\"abstract_t\">20</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Antimicrobial therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Initial empiric therapy should consist of broad-spectrum parenteral antimicrobial therapy that covers beta-lactamase&ndash;producing anaerobes [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/12\" class=\"abstract_t\">12</a>]. Options include either <a href=\"topic.htm?path=piperacillin-and-tazobactam-sodium-drug-information\" class=\"drug drug_general\">piperacillin-tazobactam</a> (4.5 g intravenously [IV] every eight hours) or <a href=\"topic.htm?path=ticarcillin-and-clavulanate-potassium-united-states-not-available-drug-information\" class=\"drug drug_general\">ticarcillin-clavulanate</a> (3.1 g IV every eight hours), <strong>plus</strong> <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> (600 to 900 mg IV every eight hours). <a href=\"topic.htm?path=vancomycin-drug-information\" class=\"drug drug_general\">Vancomycin</a> may be added when methicillin-resistant <em>S. aureus</em> is a possible pathogen (15 to 20 <span class=\"nowrap\">mg/kg</span> IV every 8 to 12 hours, not to exceed 2 g per dose).</p><p>Antibiotic therapy for CSTS should consist of penicillin (3 to 4 million units IV every four hours) plus <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> (900 mg IV every eight hours) [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. For patients with penicillin allergy, clindamycin can be used alone. No human trials have compared the efficacy of antibiotics for treatment of <em>C. sordellii</em> toxic shock syndrome; this approach is extrapolated from the treatment of traumatic gas gangrene due to <em>C. perfringens</em> and is based on animal models. (See <a href=\"topic.htm?path=clostridial-myonecrosis\" class=\"medical medical_review\">&quot;Clostridial myonecrosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Surgery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Surgery for removal of necrotic tissue and to obtain tissue for diagnostic testing is important. Case series suggest that aggressive debridement including hysterectomy may be warranted in some circumstances [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Supportive care</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Progressive hypoxia and hemodynamic instability require aggressive resuscitation with intensive care, ventilation, and vasopressive support [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. (See <a href=\"topic.htm?path=evaluation-and-management-of-suspected-sepsis-and-septic-shock-in-adults\" class=\"medical medical_review\">&quot;Evaluation and management of suspected sepsis and septic shock in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Antitoxin</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is possible that specific antitoxin may be a beneficial future therapy for <em>C. sordellii</em> infections; in a mouse model, <em>C. sordellii</em> antitoxin prevented mortality [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. There is a case report of <em>C. sordellii</em> infection in a child whose recovery was linked to the development of antibodies that neutralized the preformed toxin [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/46\" class=\"abstract_t\">46</a>].</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">OUTCOME</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>C. sordellii</em> toxic shock is frequently fatal [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. In a review of 45 cases of <em>C. sordellii</em> infections, mortality was 69 percent [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"abstract_t\">8</a>]. Mortality was 100 percent in cases associated with medical-induced abortion, spontaneous abortions, and childbirth; mortality was 50 percent in cases associated with intravenous drug use. The time from onset of symptoms to death was two to six days.</p><p class=\"headingAnchor\" id=\"H3036522264\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-skin-and-soft-tissue-infections\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Skin and soft tissue infections&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Clostridium sordellii</em> is a cause of toxic shock syndrome (CSTS) associated with gynecologic procedures, childbirth, and abortion (including spontaneous, surgical, and medical abortion). Gastrointestinal and vaginal colonization of <em>C. sordellii</em> can occur in healthy individuals. (See <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Clinical manifestations of CSTS include edema, effusions, profound leukocytosis, and hemoconcentration, followed by shock and multiorgan failure. Fever is typically absent. (See <a href=\"#H5\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The virulence of <em>C. sordellii</em> is due to production of exotoxins that may lead to CSTS even with minimal signs of local infection. Diffuse capillary leak, massive edema, and hemoconcentration are probably due to one or more exotoxins. (See <a href=\"#H2537890\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Blood cultures (both aerobic and anaerobic bottles) should be obtained; Gram stain and cultures of specimens from suspected sites of infection should be performed. <em>C. sordellii</em> is frequently identified together with other pathogens. (See <a href=\"#H8\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of <em>C. sordellii</em> toxic shock syndrome consists of antibiotic therapy, surgical debridement, and aggressive resuscitation [<a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/20\" class=\"abstract_t\">20</a>]. (See <a href=\"#H9\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Initial empiric therapy should consist of broad-spectrum parenteral antimicrobial therapy that covers beta-lactamase&ndash;producing anaerobes. For treatment of CSTS, we suggest penicillin (3 to 4 million units intravenously every four hours) plus <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> (900 mg intravenously every eight hours) (<a href=\"grade.htm?i=5\" class=\"grade\">Grade 2B</a>). (See <a href=\"#H10\" class=\"local\">'Antimicrobial therapy'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Smith LDS. Clostridium sordelli. In: The pathogenic anaerobic bacteria, 2, Charles C Thomas Publishing, Springfield 1975. p.291.</li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/2\" class=\"nounderline abstract_t\">McGregor JA, Soper DE, Lovell G, Todd JK. Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol 1989; 161:987.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/3\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol--United States and Canada, 2001-2005. MMWR Morb Mortal Wkly Rep 2005; 54:724.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/4\" class=\"nounderline abstract_t\">Fischer M, Bhatnagar J, Guarner J, et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 2005; 353:2352.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/5\" class=\"nounderline abstract_t\">Sinave C, Le Templier G, Blouin D, et al. Toxic shock syndrome due to Clostridium sordellii: a dramatic postpartum and postabortion disease. Clin Infect Dis 2002; 35:1441.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/6\" class=\"nounderline abstract_t\">Ho CS, Bhatnagar J, Cohen AL, et al. Undiagnosed cases of fatal Clostridium-associated toxic shock in Californian women of childbearing age. Am J Obstet Gynecol 2009; 201:459.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/7\" class=\"nounderline abstract_t\">Foroulis CN, Gerogianni I, Kouritas VK, et al. Direct detection of Clostridium sordellii in pleural fluid of a patient with pneumonic empyema by a broad-range 16S rRNA PCR. Scand J Infect Dis 2007; 39:617.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/8\" class=\"nounderline abstract_t\">Aldape MJ, Bryant AE, Stevens DL. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006; 43:1436.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/9\" class=\"nounderline abstract_t\">Goplerud CP, Ohm MJ, Galask RP. Aerobic and anaerobic flora of the cervix during pregnancy and the puerperium. Am J Obstet Gynecol 1976; 126:858.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/10\" class=\"nounderline abstract_t\">Bartlett JG, Onderdonk AB, Drude E, et al. Quantitative bacteriology of the vaginal flora. J Infect Dis 1977; 136:271.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/11\" class=\"nounderline abstract_t\">Chong E, Winikoff B, Charles D, et al. Vaginal and Rectal Clostridium sordellii and Clostridium perfringens Presence Among Women in the United States. Obstet Gynecol 2016; 127:360.</a></li><li class=\"breakAll\">FDA Advisory http://www.fda.gov/drugs/drugsafety/publichealthadvisories/ucm051298.html (Accessed on April 19, 2010).</li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/13\" class=\"nounderline abstract_t\">Greene MF. Fatal infections associated with mifepristone-induced abortion. N Engl J Med 2005; 353:2317.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/14\" class=\"nounderline abstract_t\">Soper DE. Abortion and clostridial toxic shock syndrome. Obstet Gynecol 2007; 110:970.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/15\" class=\"nounderline abstract_t\">Fjerstad M, Trussell J, Sivin I, et al. Rates of serious infection after changes in regimens for medical abortion. N Engl J Med 2009; 361:145.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/16\" class=\"nounderline abstract_t\">Cohen AL, Bhatnagar J, Reagan S, et al. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion. Obstet Gynecol 2007; 110:1027.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/17\" class=\"nounderline abstract_t\">Bangsberg DR, Rosen JI, Arag&oacute;n T, et al. Clostridial myonecrosis cluster among injection drug users: a molecular epidemiology investigation. Arch Intern Med 2002; 162:517.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/18\" class=\"nounderline abstract_t\">Brett MM, Hood J, Brazier JS, et al. Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiol Infect 2005; 133:575.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/19\" class=\"nounderline abstract_t\">Stevens DL, Aldape MJ, Bryant AE. Life-threatening clostridial infections. Anaerobe 2012; 18:254.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/20\" class=\"nounderline abstract_t\">Sosolik RC, Savage BA, Vaccarello L. Clostridium sordellii toxic shock syndrome: a case report and review of the literature. Infect Dis Obstet Gynecol 1996; 4:31.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/21\" class=\"nounderline abstract_t\">Wiebe E, Guilbert E, Jacot F, et al. A fatal case of Clostridium sordellii septic shock syndrome associated with medical abortion. Obstet Gynecol 2004; 104:1142.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/22\" class=\"nounderline abstract_t\">Hogan SF, Ireland K. Fatal acute spontaneous endometritis resulting from Clostridium sordelli. Am J Clin Pathol 1989; 91:104.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/23\" class=\"nounderline abstract_t\">Soper DE. Clostridial myonecrosis arising from an episiotomy. Obstet Gynecol 1986; 68:26S.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/24\" class=\"nounderline abstract_t\">Spera RV Jr, Kaplan MH, Allen SL. Clostridium sordellii bacteremia: case report and review. Clin Infect Dis 1992; 15:950.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/25\" class=\"nounderline abstract_t\">Guzzetta M, Williamson A, Duong S. Clostridium Sordellii as an Uncommon Cause of Fatal Toxic Shock Syndrome in a Postpartum 33-Year-Old Asian Woman, and the Need for Antepartum Screening for This Clostridia Species in the General Female Population. Lab Med 2016; 47:251.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/26\" class=\"nounderline abstract_t\">Bhatnagar J, Deleon-Carnes M, Kellar KL, et al. Rapid, simultaneous detection of Clostridium sordellii and Clostridium perfringens in archived tissues by a novel PCR-based microsphere assay: diagnostic implications for pregnancy-associated toxic shock syndrome cases. Infect Dis Obstet Gynecol 2012; 2012:972845.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/27\" class=\"nounderline abstract_t\">Nakamura S, Yamakawa K, Nishida S. Antibacterial susceptibility of Clostridium sordellii strains. Zentralbl Bakteriol Mikrobiol Hyg A 1986; 261:345.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/28\" class=\"nounderline abstract_t\">Martinez RD, Wilkins TD. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin). Infect Immun 1988; 56:1215.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/29\" class=\"nounderline abstract_t\">Tait AS, Dalton M, Geny B, et al. The large clostridial toxins from Clostridium sordellii and C. difficile repress glucocorticoid receptor activity. Infect Immun 2007; 75:3935.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/30\" class=\"nounderline abstract_t\">Aldape MJ, Bryant AE, Ma Y, Stevens DL. The leukemoid reaction in Clostridium sordellii infection: neuraminidase induction of promyelocytic cell proliferation. J Infect Dis 2007; 195:1838.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/31\" class=\"nounderline abstract_t\">Voth DE, Martinez OV, Ballard JD. Variations in lethal toxin and cholesterol-dependent cytolysin production correspond to differences in cytotoxicity among strains of Clostridium sordellii. FEMS Microbiol Lett 2006; 259:295.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/32\" class=\"nounderline abstract_t\">Walk ST, Jain R, Trivedi I, et al. Non-toxigenic Clostridium sordellii: clinical and microbiological features of a case of cholangitis-associated bacteremia. Anaerobe 2011; 17:252.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/33\" class=\"nounderline abstract_t\">Bouvet P, Sautereau J, Le Coustumier A, et al. Foot infection by Clostridium sordellii: case report and review of 15 cases in France. J Clin Microbiol 2015; 53:1423.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/34\" class=\"nounderline abstract_t\">Buchman AL, Ponsillo M, Nagami PH. Empyema caused by Clostridium sordellii, a rare form of pleuropulmonary disease. J Infect 1991; 22:171.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/35\" class=\"nounderline abstract_t\">File TM Jr, Fass RJ, Perkins RL. Pneumonia and empyema caused by Clostridium sordellii. Am J Med Sci 1977; 274:211.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/36\" class=\"nounderline abstract_t\">Barnes P, Leedom JM. Infective endocarditis due to Clostridium sordellii. Am J Med 1987; 83:605.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/37\" class=\"nounderline abstract_t\">Spindler AJ, Musa H. Clostridium sordelli septic arthritis. J Rheumatol 1987; 14:635.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/38\" class=\"nounderline abstract_t\">Matten J, Buechner V, Schwarz R. A rare case of Clostridium sordellii bacteremia in an immunocompromised patient. Infection 2009; 37:368.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/39\" class=\"nounderline abstract_t\">Smith C, Goslin B. Clostridium sordellii surgical site infection after breast mass excision: case report. Surg Infect (Larchmt) 2013; 14:160.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/40\" class=\"nounderline abstract_t\">Rellinger EJ, Craig BT, Craig-Owens LD, et al. Clostridium sordellii necrotizing omphalitis: A case report and literature review. J Pediatr Surg Case Rep 2016; 10:35.</a></li><li class=\"breakAll\">Lorber B. Gas gangrene and other Clostridium-associated diseases. In: Principles and Practice of Infectious Diseases, 6th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2005. p.2828.</li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/42\" class=\"nounderline abstract_t\">Bitti A, Mastrantonio P, Spigaglia P, et al. A fatal postpartum Clostridium sordellii associated toxic shock syndrome. J Clin Pathol 1997; 50:259.</a></li><li class=\"breakAll\">Stevens DL. Clostridial infections. In: Stevens DL, Mandell GL, Atlas of Infectious Diseases (Ed), Churchill Livingstone, Philadelphia 1995. p.13.1.</li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/44\" class=\"nounderline abstract_t\">Beyers R, Baldwin M, Dalabih S, Dalabih A. Clostridium sordellii as a Cause of Fatal Septic Shock in a Child with Hemolytic Uremic Syndrome. Case Rep Pediatr 2014; 2014:237674.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/45\" class=\"nounderline abstract_t\">R&oslash;rbye C, Petersen IS, Nilas L. Postpartum Clostridium sordellii infection associated with fatal toxic shock syndrome. Acta Obstet Gynecol Scand 2000; 79:1134.</a></li><li><a href=\"https://www.uptodate.com/contents/toxic-shock-syndrome-due-to-clostridium-sordellii/abstract/46\" class=\"nounderline abstract_t\">Grimwood K, Evans GA, Govender ST, Woods DE. Clostridium sordellii infection and toxin neutralization. Pediatr Infect Dis J 1990; 9:582.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5539 Version 14.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H15\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Risk factors</a><ul><li><a href=\"#H185458999\" id=\"outline-link-H185458999\">- Abortion</a></li><li><a href=\"#H185460572\" id=\"outline-link-H185460572\">- Childbirth</a></li><li><a href=\"#H185460601\" id=\"outline-link-H185460601\">- Intravenous drug use</a></li><li><a href=\"#H185460668\" id=\"outline-link-H185460668\">- Other gynecologic cases</a></li></ul></li></ul></li><li><a href=\"#H4\" id=\"outline-link-H4\">MICROBIOLOGY</a></li><li><a href=\"#H2537890\" id=\"outline-link-H2537890\">PATHOGENESIS</a></li><li><a href=\"#H14704540\" id=\"outline-link-H14704540\">PATHOLOGY</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">CLINICAL MANIFESTATIONS</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">DIAGNOSIS</a></li><li><a href=\"#H2537646\" id=\"outline-link-H2537646\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">TREATMENT</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">Antimicrobial therapy</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Surgery</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Supportive care</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Antitoxin</a></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">OUTCOME</a></li><li><a href=\"#H3036522264\" id=\"outline-link-H3036522264\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clostridial-myonecrosis\" class=\"medical medical_review\">Clostridial myonecrosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clostridium-difficile-infection-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Clostridium difficile infection in adults: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-streptococcal-toxic-shock-syndrome\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-and-management-of-suspected-sepsis-and-septic-shock-in-adults\" class=\"medical medical_review\">Evaluation and management of suspected sepsis and septic shock in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=first-trimester-medication-abortion-termination-of-pregnancy\" class=\"medical medical_review\">First-trimester medication abortion (termination of pregnancy)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=misoprostol-as-a-single-agent-for-medical-termination-of-pregnancy\" class=\"medical medical_review\">Misoprostol as a single agent for medical termination of pregnancy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=necrotizing-soft-tissue-infections\" class=\"medical medical_review\">Necrotizing soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-postpartum-hemorrhage\" class=\"medical medical_review\">Overview of postpartum hemorrhage</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=retained-products-of-conception\" class=\"medical medical_review\">Retained products of conception</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-skin-and-soft-tissue-infections\" class=\"medical medical_society_guidelines\">Society guideline links: Skin and soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=staphylococcal-toxic-shock-syndrome\" class=\"medical medical_review\">Staphylococcal toxic shock syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=uterine-perforation-during-gynecologic-procedures\" class=\"medical medical_review\">Uterine perforation during gynecologic procedures</a></li></ul></div></div>","javascript":null}